Adalyon

We provide speech-based behavioural analytics AI to pharma R&D, CROs and clinicians to deploy next-gen speech biomarkers into clinical research and practice. Using advanced NLP, LLMs, and Ayda Insights—our behavioral analytics AI—we're extracting novel speech-based digital biomarkers to Detect treatment effects earlier across therapeutic areas in digital trials Capture meaningful quality-of-life outcomes in chronic and acute conditions Bring treatments to market faster across neurological, psychiatric, and cognitive health Enable real-time, data-driven health monitoring through apps and platforms Our AI platform includes an API for compiling custom speech biomarkers, a patient app for low-friction guided voice journaling and Ayda Insights analytics service for clinicians and trial management to incorporate insights into practice.